Penicillin V is a bactericidal or bacteriostatic antibacterial agent that disrupts bacterial cell wall biosynthesis, protein synthesis, DNA replication, or membrane integrity through selective interaction with conserved prokaryotic molecular targets absent from mammalian cells. Its antibacterial spectrum, MIC distribution against relevant pathogens, and pharmacokinetic-pharmacodynamic index—time-dependent, concentration-dependent, or AUC-dependent kill kinetics—define therapeutic dosing regimens. Sensitization potential and systemic toxicity at high doses are the primary considerations driving occupational exposure limit derivation for Penicillin V in pharmaceutical manufacturing.
The pharmacologically-based OEL approach is used for Penicillin V when its receptor-mediated pharmacodynamic activity in humans produces the most sensitive adverse effect at doses below the NOAEL from general organ toxicity studies.
